A podcast by Janssen

A podcast by Janssen

With new innovative treatments becoming available, the way myeloma is perceived as a disease is changing. It has opened up the conversation on whether myeloma could become a chronic disease, or even curable in the future. However this paradigm shift also raise questions on whether to use new treatment early on, or keeping them to use in later lines. Listen to our third podcast in which Dr. Annette Vangsted talks about her perspective on how to treat multiple myeloma patients, and how to think about using new treatments and when.

Antal avsnitt: 1

Senaste avsnittet:

En podcast av: Janssen Pharmaceutica

Webb:

Podden och tillhörande omslagsbild på den här sidan tillhör Janssen Pharmaceutica. Innehållet i podden är skapat av Janssen Pharmaceutica och inte av, eller tillsammans med, Poddtoppen.